Roche is trading 3.45% higher at $59.11 on October 21, 2026, following a strong healthcare-sector advance.

  • Healthcare led U.S. sector gains on October 20; the S&P 500 healthcare index rose 2.28% and reached a record high.
  • Roche also received reported analyst upgrades, including Oddo BHF moving it to Outperform; reports do not establish these as the direct cause of the move.
  • The Hansoh partnership was announced earlier.